Search Results 1181-1190 of 21716 for heart disease in women
Xeljanz, Xeljanz XR (tofacitinib): Drug safety communication — Initial safety trial results find increased risk of serious heart-related problems and cancer ...
Learn about this condition in which one or more of the heart valves doesn't work properly.
If you have had or are at risk of breast or endometrial cancer, heart disease, stroke or blood clots, talk to your doctor about whether estrogen therapy is ...
Previous studies have shown that women with a history of preeclampsia are at greater long-term heart and kidney disease risk and are more likely to develop ...
This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. ... women for determining infant risk ...
This type also is called a cardiac resynchronization pacemaker. It's for people who have heart failure and a slow heartbeat. The device stimulates both lower ...
To return blood to the heart, the veins in the legs must work against gravity. ... Women are more likely to get the condition. ... Overview of lower extremity ...
Diseases & Conditions ... Women who have never smoked generally don't need ... Important personal information, including a family history of heart disease or ...
This medicine is also used to treat certain conditions in women before menopause if their ovaries do not make enough estrogens naturally. ... Heart disease or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.